Infectious Agents as Potential Drivers of α-Synucleinopathies
- PMID: 35040520
- DOI: 10.1002/mds.28925
Infectious Agents as Potential Drivers of α-Synucleinopathies
Abstract
α-synucleinopathies, encompassing Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, are devastating neurodegenerative diseases for which available therapeutic options are scarce, mostly because of our limited understanding of their pathophysiology. Although these pathologies are attributed to an intracellular accumulation of the α-synuclein protein in the nervous system with subsequent neuronal loss, the trigger(s) of this accumulation is/are not clearly identified. Among the existing hypotheses, interest in the hypothesis advocating the involvement of infectious agents in the onset of these diseases is renewed. In this article, we aimed to review the ongoing relevant factors favoring and opposing this hypothesis, focusing on (1) the potential antimicrobial role of α-synuclein, (2) potential entry points of pathogens in regard to early symptoms of diverse α-synucleinopathies, (3) pre-existing literature reviews assessing potential associations between infectious agents and Parkinson's disease, (4) original studies assessing these associations for dementia with Lewy bodies and multiple system atrophy (identified through a systematic literature review), and finally (5) potential susceptibility factors modulating the effects of infectious agents on the nervous system. © 2022 International Parkinson and Movement Disorder Society.
Keywords: Parkinson's disease; dementia with Lewy bodies; infections; multiple system atrophy; α-synuclein.
© 2022 International Parkinson and Movement Disorder Society.
References
-
- Hayes MT. Parkinson's disease and parkinsonism. Am J Med 2019;132:802-807. https://doi.org/10.1016/j.amjmed.2019.03.001
-
- Jellinger KA. Multiple system atrophy: an Oligodendroglioneural Synucleinopathy1. J Alzheimers Dis 2018;62:1141-1179. https://doi.org/10.3233/JAD-170397
-
- McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 2017;89:88-100. https://doi.org/10.1212/WNL.0000000000004058
-
- Tysnes O-B, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna) 2017;124:901-905. https://doi.org/10.1007/s00702-017-1686-y
-
- Vann Jones SA, O'Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 2014;44:673-683. https://doi.org/10.1017/S0033291713000494